| Literature DB >> 33694113 |
Kai Zhao1, Jing Li2, Chaonan Du1, Qiang Zhang3, Yu Guo1, Mingfei Yang4.
Abstract
Ambient fine particulate matter of 2.5 μm or less in diameter (PM2.5) of environment contamination is deemed as a risk factor of cerebrovascular diseases. Yet there is still no explicit evidence strongly supporting that PM2.5 with per unit increment can increase the risk of hemorrhagic stroke (HS). Literatures were searched from PubMed, Cochrane, and Embase. After the systemic review of relevant studies, random effects model was used to perform meta-analysis and to evaluate the association between PM2.5 and risk of HS. Seven cohort studies were finally included, involving more than 6 million people and 37,667 endpoint events (incidence or mortality of HS). Total scores of quality assessment were 50. Pooled hazard ratio (HR) for crude HRs was 1.13 (95%CI: 1.09-1.17) (CI for confidence interval). Pooled HR of subgroup analysis for current smoking with exposure to growing PM2.5 was 1.14 (95%CI: 0.92-2.15) and for never and former smoking was 1.04 (95%CI: 0.74-1.46). Ambient PM2.5 level is significantly associated with the risk of HS, which might be a potential risk factor of HS. Smoking does not further increase the risk of HS under exposure of PM2.5.Entities:
Keywords: Hazard ratio; Hemorrhagic stroke; Meta-analysis; PM2.5
Mesh:
Substances:
Year: 2021 PMID: 33694113 PMCID: PMC8106587 DOI: 10.1007/s11356-021-13074-7
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 4.223
Fig. 1Process of searching for studies and screening
Characters of studies included finally
| Authors | Year of publication | Area | Increase of PM2.5 (μg/m3) | Study population | Exposure period | Age (years) | Gender (male, %) | Endpoints cases | Definition of endpoint |
|---|---|---|---|---|---|---|---|---|---|
| Keyong Huang et al. | 2019 | China | 10 | 117575 | 2000–2015 | 50.9 ± 11.8 | 41.0 | 1019 | ICD-10 I60,I61,I62 |
| Yutong Cai et al. | 2018 | UK | 1.4 | 355732 | 1993–2013 | 52.9 ± 10.6 | 42.0 | 307 | ICD-9 431;ICD-10 I60,I61,I62 |
| George S Downward et al. | 2018 | Netherlands | 5 | 33831 | 1993–2010 | 50.0 ± 11.0 | 23.0 | 241 | ICD |
| Jong-Hun Kim et al. | 2018 | Korea | 10 | 40% of national population | 1990–2013 | Null | Null | 12,832 | ICD-10 I60,I61,I62,I690,I691, I692,I694 |
| Hong Qiu et al. | 2017 | Hong Kong, China | 10 | 66820 | 1998–2001 | 72 | 34.1 | 1175 | ICD-9 430,431 |
| Saeha Shin et al. | 2019 | Canada | 4.1 | 5071956 | 2001–2015 | 53.2 ± 12.9 | 48.0 | 21,581 | ICD-9 430,431;ICD-10 I60,I61 |
| Juhwan Noh et al. | 2019 | Korea | 10 | 62676 | 2002–2013 | ≥ 20 | 49.3 | 512 | ICD-10 I60–I62 |
Quality assessment for studies included
| Year of publication | Authors | Selection | Comparability | Outcome | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Representative participants | Illustration of non-exposed cohort | Ascertainment for exposure | No endpoints presented at beginning | Definition of endpoints | Long enough time for exposure | Adequacy of follow-up | ||||
| 2019 | Keyong Huang et al. | 8 | ||||||||
| 2018 | Yutong Cai et al. | 7 | ||||||||
| 2018 | GeorgeS Downward et al. | 7 | ||||||||
| 2018 | Jong-Hun Kim et al. | 7 | ||||||||
| 2017 | Hong Qiu et al. | 7 | ||||||||
| 2019 | Saeha Shin et al. | 7 | ||||||||
| 2019 | Juhwan Noh et al. | 7 | ||||||||
Fig. 2a Pooled HR for crude HRs. b Funnel diagram and Egger’s regression of crude HRs
Crude HRs omitted one by one and pooled HRs of the rest studies
| Article deleted | Pooled HR (95%CI) | Test of heterogeneity | |
|---|---|---|---|
| I2 (%) | |||
| Keyong Huang et al. | 1.08 (1.02, 1.14) | 42.0 | 0.125 |
| Yutong Cai et al. | 1.10 (1.04, 1.17) | 70.1 | 0.005 |
| GeorgeS Downward et al. | 1.09 (1.03, 1.16) | 69.2 | 0.006 |
| Jong-Hun Kim et al. | 1.09 (1.01, 1.16) | 66.7 | 0.010 |
| Hong Qiu et al. | 1.10 (1.04,1.17) | 70.3 | 0.005 |
| Saeha Shin et al. | 1.13 (1.09,1.17) | 0.0 | 0.599 |
| Juhwan Noh et al. | 1.09 (1.02,1.16) | 69.2 | 0.006 |
Fig. 3a Pooled HR for HRs adjusted for different covariates. b Funnel diagram and Egger’s regression of HRs adjusted for covariates
HRs adjusted for covariates omitted one by one and Pooled HRs of the rest studies
| Article deleted | Pooled HR (95%CI) | Test of heterogeneity | |
|---|---|---|---|
| I2 (%) | |||
| Keyong Huang et al. | 1.19 (1.01, 1.39) | 89.4 | 0.000 |
| Yutong Cai et al. | 1.18 (1.05, 1.34) | 89.8 | 0.000 |
| GeorgeS Downward et al. | 1.15 (1.03, 1.29) | 89.7 | 0.000 |
| Jong-Hun Kim et al. | 1.18 (1.01, 1.38) | 89.2 | 0.000 |
| Hong Qiu et al. | 1.19 (1.06,1.35) | 89.5 | 0.000 |
| Saeha Shin et al. | 1.22 (1.02,1.44) | 87.0 | 0.000 |
| Juhwan Noh et al. | 1.08 (1.02,1.14) | 54.6 | 0.051 |
Fig. 4a Subgroup analysis for smoking. b Sensitivity analysis for subgroup analysis by switching effects models